RLAY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Relay Therapeutics (RLAY) Earnings Date & Reports

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLAY is expected to report earnings to rise 15.60% to -52 cents per share on May 01

Relay Therapeutics RLAY Stock Earnings Reports

Q1'25

Est.

$-0.52

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.12

The last earnings report on February 26 showed earnings per share of -44 cents, beating the estimate of -56 cents. With 751.78K shares outstanding, the current market capitalization sits at 389.05M.

View a ticker or compare two or three

Compare

RLAY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RLAY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

399 Binney Street

Phone

+1 617 370-8837

Employees

323

Web

https://www.relaytx.com